Certified by Founder
Lodge
AstronauTx
start up
United Kingdom
- London, England
- 09/10/2023
- Series A
- $58,462,000
AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease.
- Industry Biotechnology Research
- Website https://astronautx.bio/
- LinkedIn https://www.linkedin.com/company/astronautx/about/
Ultralight | $9,300,000 | (Apr 21, 2026)
Sage Haven | $3,000,000 | (Apr 21, 2026)
CREAO AI | $10,000,000 | (Apr 21, 2026)
ViewsML | $4,900,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
Wavelet Medical | $7,000,000 | (Apr 21, 2026)
Rivan Industries | $34,000,000 | (Apr 21, 2026)
urfuture | $2,299,785 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Giggles | $1,000,000 | (Apr 21, 2026)
brainjo GmbH | $2,356,020 | (Apr 21, 2026)
Coral | $12,500,000 | (Apr 21, 2026)